Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $3.41, but opened at $10.22. Curaleaf shares last traded at $9.9125, with a volume of 47,784 shares changing hands.

Analysts Set New Price Targets

Separately, Zacks Research cut Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy”.

Curaleaf Stock Performance

The stock’s fifty day moving average price is $7.64 and its 200-day moving average price is $7.51. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56. The company has a market capitalization of $2.25 billion, a P/E ratio of -24.74 and a beta of 1.51.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.51. The firm had revenue of $324.23 million for the quarter, compared to analysts’ expectations of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. As a group, research analysts anticipate that Curaleaf Holdings, Inc. will post -0.31 EPS for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.